Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.

Although the sample size did not allow reaching a statistically significant difference between HRP and HRD samples, a clear trend in higher expression of miR-506 in samples defined HRD, particularly by RAD51 assay, was evident ( Supplementary Figure S2 D, available at https://doi.org/10.1016/j.esmoop.2024.104091 ).

also in 19,460 other papers